Trials / Completed
CompletedNCT00141336
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
Pregabalin BID Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 750 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin |
Timeline
- Start date
- 1999-11-01
- Completion
- 2005-07-01
- First posted
- 2005-09-01
- Last updated
- 2007-01-01
Locations
103 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00141336. Inclusion in this directory is not an endorsement.